C&R Research Inc. (KOSDAQ:359090)
South Korea · Delayed Price · Currency is KRW 1,952.00
+26.00 (1.35%)
At close: Aug 11, 2026
C&R Research Market Cap
C&R Research has a market cap or net worth of 22.44 billion as of August 11, 2026. Its market cap has decreased by -61.60% in one year.
Market Cap
22.44B
Enterprise Value
23.95B
Revenue
62.70B
Ranking
n/a
PE Ratio
9.59
Stock Price
1,952.00
ChartMarket Cap Chart
Since December 9, 2021, C&R Research's market cap has increased from 19.05B to 22.44B, an increase of 17.78%. That is a compound annual growth rate of 3.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 22.44B | -56.62% |
| Dec 30, 2025 | 51.72B | -21.53% |
| Dec 30, 2024 | 65.91B | 0.98% |
| Dec 28, 2023 | 65.27B | 5.47% |
| Dec 29, 2022 | 61.89B | -42.89% |
| Dec 30, 2021 | 108.38B | 468.92% |
| Dec 9, 2021 | 19.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 211.93B |
| DreamCIS | 83.40B |
| P&K Skin Research Center | 52.33B |
| Kolmar BioTech | 39.30B |
| HLB bioStep | 35.80B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 23.52B |
| Curachem | 12.65B |